DarioHealth Corp.
DRIO
$6.28
$0.223.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -17.30% | -31.21% | -32.55% | -14.16% | 17.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.30% | -31.21% | -32.55% | -14.16% | 17.26% |
| Cost of Revenue | 10.63% | 6.24% | -17.76% | -12.97% | -7.77% |
| Gross Profit | -29.01% | -45.63% | -38.79% | -14.84% | 32.32% |
| SG&A Expenses | -11.53% | -11.44% | -12.33% | -30.44% | -32.70% |
| Depreciation & Amortization | -79.77% | -85.95% | -86.53% | -64.88% | -24.76% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.22% | -25.62% | -25.51% | -35.09% | -31.56% |
| Operating Income | 22.32% | 21.73% | 21.16% | 43.18% | 47.30% |
| Income Before Tax | 11.00% | 5.58% | 15.21% | 4.56% | -0.39% |
| Income Tax Expenses | 159.09% | -46.45% | -- | -- | 101.10% |
| Earnings from Continuing Operations | 10.60% | 6.24% | 15.12% | 4.56% | -28.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.60% | 6.24% | 15.12% | 4.56% | -28.60% |
| EBIT | 22.32% | 21.73% | 21.16% | 43.18% | 47.30% |
| EBITDA | 16.78% | 8.81% | 9.74% | 41.49% | 50.67% |
| EPS Basic | 56.31% | 17.99% | 39.75% | -109.14% | 28.58% |
| Normalized Basic EPS | 67.98% | 49.00% | 45.39% | 23.40% | 27.00% |
| EPS Diluted | 56.31% | 17.99% | 39.75% | -109.14% | 28.58% |
| Normalized Diluted EPS | 67.98% | 49.00% | 45.39% | 23.40% | 27.00% |
| Average Basic Shares Outstanding | 177.91% | 100.58% | 55.28% | 24.60% | 37.54% |
| Average Diluted Shares Outstanding | 177.91% | 100.58% | 55.28% | 24.60% | 37.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |